Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Norihiro Saito, Masamichi Itoga, Satoko Minakawa & Hiroyuki Kayaba. (2021) Serum 3-Hydroxybutyrate in Patients with Psychogenic Somatoform Symptoms May Be a Predictor of the Effectiveness of Sertraline and Venlafaxine. International Journal of General Medicine 14, pages 1785-1795.
Read now
Read now
Jihui Wang, Qinling Wei, Xiaoli Wu, Zhiyong Zhong & Guanying Li. (2016) Brief behavioral treatment for patients with treatment-resistant insomnia. Neuropsychiatric Disease and Treatment 12, pages 1967-1975.
Read now
Read now
Ingunn Fride Tvete, Trine Bjørner & Tor Skomedal. (2015) Risk factors for excessive benzodiazepine use in a working age population: a nationwide 5-year survey in Norway. Scandinavian Journal of Primary Health Care 33:4, pages 252-259.
Read now
Read now
Rita de Cássia da Silveira e Sá, Reinaldo Nóbrega de Almeida & Jnanabrata Bhattacharyya. (2013) Pharmaceutical properties and toxicology of Dioclea grandiflora. Pharmaceutical Biology 51:5, pages 659-667.
Read now
Read now
Sabine Saade & Alain Marchand. (2013) Work Organization Conditions and Prescribed Psychotropic Drug Use in Canada: The Moderating Role of Personality Traits. Journal of Workplace Behavioral Health 28:1, pages 62-80.
Read now
Read now
Salvatore Chirumbolo. (2012) Plant-Derived Extracts in the Neuroscience of Anxietyon Animal Models: Biases and Comments. International Journal of Neuroscience 122:4, pages 177-188.
Read now
Read now
Articles from other publishers (43)
JoAnn Difede, Andrew A. McAleavey, Mariel Emrich, Adina Jick, Annell Ovalles, Katarzyna Wyka, Lisa Spielman, Megan Olden, Melissa Peskin, Colleen Becket-Davenport, Amy Rubenstein, Michael J. Brownstein, Eve Damiano, Debra Itzkowitz, Shi-fang Lu, Nancy J. Needell, James H. Kocsis, Janna S. Gordon-Elliott & Neal G. Simon. (2023) A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment. Contemporary Clinical Trials Communications 33, pages 101116.
Crossref
Crossref
Ung Gu Kang, Se Hyun Kim, Nam Young Lee, Kyu Young Lee, Yong Sik Kim & In Won Chung. (2023) Benzodiazepines: Pharmacology Up-to-Date and Practical Issues. Journal of Korean Neuropsychiatric Association 62:1, pages 1.
Crossref
Crossref
Shun Zhu, Fang Liu, Ruiyuan Zhang, Zongxiang Xiong, Qian Zhang, Li Hao & Shiyin Chen. (2022) Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders. Frontiers in Pharmacology 13.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
231
269
.
Andrew Dodson, Kevin Mi, Daniel P. Russo, Christina Scott, Muriel Saulnier, Kevin Snyder & Rebecca Racz. (2021) Aggregation and analysis of secondary pharmacology data from investigational new drug submissions at the US Food and Drug Administration. Journal of Pharmacological and Toxicological Methods 111, pages 107098.
Crossref
Crossref
Babak Hosseinzadeh Zoroufchi, Hoda Doustmohammadi, Tahmineh Mokhtari & Abolfazl Abdollahpour. (2021) Benzodiazepines related sexual dysfunctions: A critical review on pharmacology and mechanism of action. Revista Internacional de Andrología 19:1, pages 62-68.
Crossref
Crossref
Jeffrey Glennon. 2021. Encyclopedia of Autism Spectrum Disorders. Encyclopedia of Autism Spectrum Disorders
4117
4120
.
SR SanthoshS SampathA Gupta. (2019) Simultaneous analysis of eight benzodiazepines in blood and urine matrix by gas chromatography–mass spectrometry: Implications for air crash investigation. Indian Journal of Aerospace Medicine 63, pages 2-7.
Crossref
Crossref
Yun Yang, Yue Xu & Christopher R. Jones. (2019) A Ring Expansion Route to Benzofused N‐Heterocycles Through Aryne Insertion into 1,3‐Diaza‐heterocycles. European Journal of Organic Chemistry 2019:31-32, pages 5196-5200.
Crossref
Crossref
Hugo P. Collin, Wallace J. Reis, Dennis U. Nielsen, Anders T. Lindhardt, Marcelo S. Valle, Rossimiriam P. Freitas & Troels Skrydstrup. (2019) COtab: Expedient and Safe Setup for Pd-Catalyzed Carbonylation Chemistry. Organic Letters 21:15, pages 5775-5778.
Crossref
Crossref
Sumit D. Agarwal & Bruce E. Landon. (2019) Patterns in Outpatient Benzodiazepine Prescribing in the United States. JAMA Network Open 2:1, pages e187399.
Crossref
Crossref
Louise Wingård, Heidi Taipale, Johan Reutfors, Anna Westerlund, Robert Bodén, Jari Tiihonen, Antti Tanskanen & Morten Andersen. (2018) Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder. Bipolar Disorders 20:7, pages 634-646.
Crossref
Crossref
Erez Berman, Sara Eyal & Eli Marom. (2017) Trends in utilization of benzodiazepine and Z-drugs in Israel. Pharmacoepidemiology and Drug Safety 26:12, pages 1555-1560.
Crossref
Crossref
Louis Jacob, Michael A. Rapp & Karel Kostev. (2017) Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis. Therapeutic Advances in Psychopharmacology 7:6-7, pages 191-200.
Crossref
Crossref
Longtu Chen, Sheikh J. Ilham & Bin Feng. (2017) Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article. Anesthesiology and Pain Medicine 7:2.
Crossref
Crossref
Martin J. Brodie, Steve Chung, Alan Wade, Céline Quelen, Alice Guiraud-Diawara, Clément François, Patrice Verpillat, Vivienne Shen & Jouko Isojarvi. (2016) Clobazam and clonazepam use in epilepsy: Results from a UK database incident user cohort study. Epilepsy Research 123, pages 68-74.
Crossref
Crossref
Ingunn Fride Tvete, Trine Bjørner & Tor Skomedal. (2016) A 5-year follow-up study of users of benzodiazepine: starting with diazepam versus oxazepam. British Journal of General Practice 66:645, pages e241-e247.
Crossref
Crossref
Patricia J. Robinson & Jeffrey T. ReiterPatricia J. Robinson & Jeffrey T. Reiter. 2016. Behavioral Consultation and Primary Care. Behavioral Consultation and Primary Care
269
286
.
T.A.T. Kurko, L.K. Saastamoinen, S. Tähkäpää, A. Tuulio-Henriksson, T. Taiminen, J. Tiihonen, M.S. Airaksinen & J. Hietala. (2015) Long-term use of benzodiazepines: Definitions, prevalence and usage patterns – a systematic review of register-based studies. European Psychiatry 30:8, pages 1037-1047.
Crossref
Crossref
Haritz Jiménez-Urbieta, Belén Gago, Patricia de la Riva, Manuel Delgado-Alvarado, Concepció Marin & María C. Rodriguez-Oroz. (2015) Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches. Neuroscience & Biobehavioral Reviews 56, pages 294-314.
Crossref
Crossref
Paulina Szatkowska, Marcin Koba, Piotr Kośliński, Jacek Wandas & Tomasz Bączek. (2014) Analytical methods for determination of benzodiazepines. A short review. Open Chemistry 12:10, pages 994-1007.
Crossref
Crossref
Amal Rabahi, Safouane M. Hamdi, Yahia Rachedi, Maamar Hamdi, Oualid Talhi, Filipe A. Almeida Paz, Artur S.M. Silva, Balegroune Fadila, Hamadène Malika & Taïbi Kamel. (2014) 2D-NMR, X-ray crystallography and theoretical studies of the reaction mechanism for the synthesis of 1,5-benzodiazepines from dehydroacetic acid derivatives and o-phenylenediamines. Journal of Molecular Structure 1061, pages 97-103.
Crossref
Crossref
Elizabeth CM de Lange. 2014. Applied Pharmacometrics. Applied Pharmacometrics
407
449
.
Andre R. Brunoni, Maria Angélica Nunes, Roberta Figueiredo, Sandhi M. Barreto, Maria de Jesus Mendes da Fonseca, Paulo A. Lotufo & Isabela M. Benseñor. (2013) Patterns of benzodiazepine and antidepressant use among middle-aged adults. The Brazilian longitudinal study of adult health (ELSA-Brasil). Journal of Affective Disorders 151:1, pages 71-77.
Crossref
Crossref
Dhananjay Kumar, Bhuwan Mishra, Divya Kushwaha & Vinod Tiwari. 2013. Chemistry and Pharmacology of Naturally Occurring Bioactive Compounds. Chemistry and Pharmacology of Naturally Occurring Bioactive Compounds
9
30
.
Trine Bjørner, Ingunn Fride Tvete, Ivar Aursnes †Tor Skomedal. (2013) Utlevering av benzodiazepiner og z-hypnotika fra norske apotek 2004 – 11. Tidsskrift for Den norske legeforening 133:20, pages 2149-2153.
Crossref
Crossref
Philippe Huot, Tom H. Johnston, James B. Koprich, Susan H. Fox & Jonathan M. Brotchie. (2013) The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease. Pharmacological Reviews 65:1, pages 171-222.
Crossref
Crossref
Ariel Berger, John Edelsberg, Michael Treglia, Jose Ma J Alvir & Gerry Oster. (2012) Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study. BMC Psychiatry 12:1.
Crossref
Crossref
Joanne Bowes, Andrew J. Brown, Jacques Hamon, Wolfgang Jarolimek, Arun Sridhar, Gareth Waldron & Steven Whitebread. (2012) Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. Nature Reviews Drug Discovery 11:12, pages 909-922.
Crossref
Crossref
Carla Beth Marienfeld, Ece Tek, Esperanza Diaz, Richard Schottenfeld & Marek Chawarski. (2012) Psychiatrist Decision-Making Towards Prescribing Benzodiazepines: The Dilemma with Substance Abusers. Psychiatric Quarterly 83:4, pages 521-529.
Crossref
Crossref
Dani Brunner, Fuat Balcı & Elliot A. Ludvig. (2012) Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration. Behavioural Processes 89:2, pages 187-195.
Crossref
Crossref
Charles D. Ciccone. 2012. Geriatric Physical Therapy. Geriatric Physical Therapy
38
63
.
Ariel Berger, John Edelsberg, Vamsi Bollu, Jose Ma J Alvir, Ashish Dugar, Ashish V Joshi & Gerry Oster. (2011) Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study. BMC Psychiatry 11:1.
Crossref
Crossref
Hideaki Kanemura, Fumikazu Sano, Kanji Sugita & Masao Aihara. (2011) Effects of Ethyl Loflazepate on Refractory Epilepsy in Children. Journal of Child Neurology 26:10, pages 1284-1289.
Crossref
Crossref
Tien-Hsiung Ku, Yih-Jing Lee, Su-Jane Wang, Chen-Hua Fan & Lu-Tai Tien. (2011) Effect of honokiol on activity of GAD65 and GAD67 in the cortex and hippocampus of mice. Phytomedicine 18:13, pages 1126-1129.
Crossref
Crossref
Jayne E BaileyGerard R DawsonColin T DourishDavid J Nutt. (2011)
Validating the inhalation of 7.5% CO
2
in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD)
. Journal of Psychopharmacology 25:9, pages 1192-1198.
Crossref
Crossref
Célyne H. Bastien. (2011) Insomnia: Neurophysiological and NeuropsychologicalApproaches. Neuropsychology Review 21:1, pages 22-40.
Crossref
Crossref
Xiang Bai & Lisa R. Gerak. (2010) Comparing the discriminative stimuli produced by either the neuroactive steroid pregnanolone or the benzodiazepine midazolam in rats. Psychopharmacology 214:2, pages 427-435.
Crossref
Crossref
David J. Greenblatt, Jerold S. Harmatz & Richard I. Shader. (2011) Psychotropic Drug Prescribing in the United States. Journal of Clinical Psychopharmacology 31:1, pages 1-3.
Crossref
Crossref
Majda Azermai, Monique Elseviers, Mirko Petrovic, Luc Van Bortel & Robert Vander Stichele. (2011) Geriatric drug utilisation of psychotropics in Belgian nursing homes. Human Psychopharmacology: Clinical and Experimental 26:1, pages 12-20.
Crossref
Crossref
Michael S. DahlJimmi Nielsen & Ramin Mojtabai. (2010) The effects of becoming an entrepreneur on the use of psychotropics among entrepreneurs and their spouses. Scandinavian Journal of Public Health 38:8, pages 857-863.
Crossref
Crossref
Paolo Magnani, Anita Conforti, Elisabetta Zanolin, Marta Marzotto & Paolo Bellavite. (2010) Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice. Psychopharmacology 210:4, pages 533-545.
Crossref
Crossref
Jean-Marc Cloos & Valérie Ferreira. (2009) Current use of benzodiazepines in anxiety disorders. Current Opinion in Psychiatry 22:1, pages 90-95.
Crossref
Crossref